Abstract
Recent reports of risk factors for and survival of patients with diabetic retinopathy do not include exudative maculopathy as a separate entity.
We therefore studied a group of hypertensive Type II diabetic subjects with exudative maculopathy (n = 26) compared to a carefully matched hypertensive diabetic comparison group without retinopathy (n = 26) over seven years.
Diabetic maculopathy patients had higher mean diastolic blood pressure (101.6 ± 14 versus 94.8 ± 10 mmHg, p<0.05), serum cholesterol (6.65 ± 2.2 versus 5.9 ± 1.31 mmol/l), HDL2 subfraction levels (0.46 ± 0.23 versus 0.32 ± 0.18 mmol/l) and a higher prevalence of hyperlipidaemia (54% versus 35%) compared to the comparison group.
After seven years, the maculopathy group showed a strikingly higher prevalence of renal failure and nephrotic syndrome (42% versus 8%, p<0.05) and of macro-proteinuria (58% versus 15%, p<0.01) compared to the comparison group. Mortality and cardiovascular disease event rate was 12% and 38% in the maculopathy and 15% and 31% respectively in the comparison group.
We conclude that although mortality is not significantly higher in diabetics with exudative maculopathy, proteinuria, renal failure and nephrotic syndrome may be associated features on long term follow-up. Hypertension and hypercholesterolae-mia may also be risk factors in the development of diabetic maculopathy.
Similar content being viewed by others
Article PDF
References
Ghafour I, Allan D, Foulds WS : Common causes of blindness and visual handicap in the West of Scotland. Br J Ophthalmol 1983, 67: 209–13.
Bresnick GH : Diabetic maculopathy: A critical review highlighting diffuse macular oedema. Ophthalmology 1983; 90: 1301–17.
Pacy PJ, Dodson PM, Beevers M, Fletcher RF, Taylor KG : Prevalence of hypertension in White, Black, and Asian diabetics in a district hospital diabetic clinic. Diabetic Medicine 1985, 1: 125–30.
World Health Organisation. Report of the WHO Expert Committee on Hypertension. WHO Technical Report Services, Number 646 1987.
Maxwell MM, Waks AV, Schroth PC, Karam C, Dornfeld LP : Error in blood pressure measurement due to incorrect cuff size in obese patients. Lancet 1982, ii: 33–35.
The British Hyperlipidaemia Association: Detection and management of blood lipid disorders. Current Science 1990.
Burstein M, Scholmick HR, Morfin R : Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970, ii: 583–95.
Ferns GA, Galton D, Landon J, Williams PJ : Measurement of high density lipoprotein subfraction 2 (HDL2) by a simple precipitation method. Clin Sci 1981; 62: 16–17.
Pacy PJ, Dodson PM, Kubicki AJ, Fletcher RF, Taylor KG : Comparison of the hypotensive and metabolic effects of bendrofluazide therapy and a high fibre, low fat and low sodium diet in diabetic subjects with mild hypertension. J Hypertens 1984, 2: 215–20.
Dodson PM, Galton DJ, Hamilton AM, Blach RK : Retinal vein occlusion and the prevalence of lipoprotein abnormalities. Br J Ophthalmol 1982, 66: 161–64.
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL : The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 1984, 102: 527–32.
Reckless JPD, Betteridge DJ, Wu P, Payne B, Calton DJ : High density and low density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J 1978; i: 883–6.
Garcia MJ, McNamara PM, Gordon T, Kannel WB : Morbidity and mortality in diabetics in the Fra-mingham population: Sixteen year follow-up. Diabetes 1974, 23: 105–11.
Harrold BP, Marmion VJ, Gough KRG : A double blind controlled study of clofibrate in the treatment of diabetic retinopathy. Diabetes 1969, 18: 285–91.
Esmann V, Kundbaek K, Madsen PH : Types of exu-dates in diabetic retinopathy. Acta Med Scand 1963, 174: 375–80.
Kasiske BL, O'Donnell MP, Garvis WJ, et al.: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Cir Res 1988, 62: 367–74.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dodson, P., Gibson, J. Long term follow-up of and underlying medical conditions in patients with diabetic exudative maculopathy. Eye 5, 699–703 (1991). https://doi.org/10.1038/eye.1991.128
Issue Date:
DOI: https://doi.org/10.1038/eye.1991.128
This article is cited by
-
The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst
Journal of Negative Results in BioMedicine (2005)
-
Medical treatment of diabetic retinopathy
Eye (2003)
-
The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?
Eye (2002)
-
Diabetestherapie in der Praxis — Statistische Auswertung einer Fortbildungsveranstaltung
Spektrum der Augenheilkunde (1998)
-
Medical cardiovascular treatment trials: Relevant to medical ophthalmology in 1997?
Eye (1997)